Iguratimod treatment reduces disease activity in early primary Sjögren's syndrome: An open-label pilot study.
Chen H, Qi X, Li Y, Wu Q, Shi Q, Wang L, Li J, Zhao L, Zhang L, Zhou X, Fei Y, Liu J, Su J, Wu D, Yang Y, Jiang H, Zeng X, Zhang F, Zhao Y.
Chen H, et al. Among authors: wu d, wu q.
Mod Rheumatol. 2021 Mar;31(2):394-398. doi: 10.1080/14397595.2020.1789335. Epub 2020 Aug 3.
Mod Rheumatol. 2021.
PMID: 32613869